67 related articles for article (PubMed ID: 21378433)
1. Systemic melioidiosis.
Dias E; Dias M
Indian Pediatr; 2011 Feb; 48(2):161. PubMed ID: 21378433
[No Abstract] [Full Text] [Related]
2. Why is the response rate slow in ceftazidime therapy for melioidosis?
Puthucheary SD; Sam IC
Expert Rev Anti Infect Ther; 2012 Jan; 10(1):5-7. PubMed ID: 22149608
[No Abstract] [Full Text] [Related]
3. Cutaneous melioidosis.
Teo L; Tay YK; Mancer KJ
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1322-4. PubMed ID: 17062053
[TBL] [Abstract][Full Text] [Related]
4. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
Feterl M; Govan B; Engler C; Norton R; Ketheesan N
Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
[TBL] [Abstract][Full Text] [Related]
5. Melioidosis of the spleen diagnosed by 16S rDNA amplification and sequencing.
Chlebicki MP; Tan BH; Koh TH
Scand J Infect Dis; 2005; 37(6-7):517-20. PubMed ID: 16012017
[TBL] [Abstract][Full Text] [Related]
6. Variable presentation of neurological melioidosis in Northeast Thailand.
Limmathurotsakul D; Chaowagul W; Wongsrikaew P; Narmwong A; Day NP; Peacock SJ
Am J Trop Med Hyg; 2007 Jul; 77(1):118-20. PubMed ID: 17620641
[TBL] [Abstract][Full Text] [Related]
7. Burkholderia pseudomallei - a rare cause for septic arthritis.
Karuppal R; Marthya A; Justus S; Kumaran CM; Padinjareyil G
Joint Bone Spine; 2007 Dec; 74(6):659-60. PubMed ID: 17913555
[No Abstract] [Full Text] [Related]
8. A role for carbapenem in the treatment of melioidosis in developing countries?
Laowansiri P; Shah S; Kiratisin P; Apisarnthanarak A
Int J Infect Dis; 2009 Sep; 13(5):e331-2. PubMed ID: 19231268
[No Abstract] [Full Text] [Related]
9. Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: a case report.
Visca P; Cazzola G; Petrucca A; Braggion C
Clin Infect Dis; 2001 Jan; 32(1):E15-6. PubMed ID: 11112669
[TBL] [Abstract][Full Text] [Related]
10. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis.
Chierakul W; Anunnatsiri S; Short JM; Maharjan B; Mootsikapun P; Simpson AJ; Limmathurotsakul D; Cheng AC; Stepniewska K; Newton PN; Chaowagul W; White NJ; Peacock SJ; Day NP; Chetchotisakd P
Clin Infect Dis; 2005 Oct; 41(8):1105-13. PubMed ID: 16163628
[TBL] [Abstract][Full Text] [Related]
11. Neurologic melioidosis in a child: unique clinical features and challenges of serologic diagnosis.
Cohn A; Norton R; Walsh M; Nourse C
Pediatr Infect Dis J; 2012 Nov; 31(11):1197-8. PubMed ID: 22760535
[TBL] [Abstract][Full Text] [Related]
12. Ceftazidime resistance in Burkholderia pseudomallei: first report from India.
Behera B; Prasad Babu TL; Kamalesh A; Reddy G
Asian Pac J Trop Med; 2012 Apr; 5(4):329-30. PubMed ID: 22449529
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis.
Chetchotisakd P; Porramatikul S; Mootsikapun P; Anunnatsiri S; Thinkhamrop B
Clin Infect Dis; 2001 Jul; 33(1):29-34. PubMed ID: 11389491
[TBL] [Abstract][Full Text] [Related]
14. Differential antibiotic-induced endotoxin release in severe melioidosis.
Simpson AJ; Opal SM; Angus BJ; Prins JM; Palardy JE; Parejo NA; Chaowagul W; White NJ
J Infect Dis; 2000 Mar; 181(3):1014-9. PubMed ID: 10720525
[TBL] [Abstract][Full Text] [Related]
15. Multiple visceral abscess in a case of melioidosis.
Navaneethan U; Ramesh Kumar AC; Ravi G
Indian J Med Sci; 2006 Feb; 60(2):68-70. PubMed ID: 16505577
[No Abstract] [Full Text] [Related]
16. Melioidosis.
Krishnan P; Fernandes S; Savio J; Ross CR; Pradeep R; Choudhary R; Shet AS; Pais P
J Assoc Physicians India; 2008 Aug; 56():636-9. PubMed ID: 19051712
[TBL] [Abstract][Full Text] [Related]
17. Melioidosis presenting as sepsis syndrome: a case report.
Redondo MC; Gómez M; Landaeta ME; Ríos H; Khalil R; Guevara RN; Palavecino S; Figuera M; Caldera J; Rivera R; Calvo A; Vitelli J; Morón M; Nuñez MJ
Int J Infect Dis; 2011 Mar; 15(3):e217-8. PubMed ID: 21195650
[TBL] [Abstract][Full Text] [Related]
18. In vitro interactions between cotrimoxazole and doxycycline in Burkholderia pseudomallei: how important is this combination in maintenance therapy of melioidosis?
Saraya S; Soontornpas C; Chindavijak B; Mootsikapun P
Indian J Med Microbiol; 2009; 27(1):88-9. PubMed ID: 19172079
[No Abstract] [Full Text] [Related]
19. Neonatal melioidosis: a case report from India.
Noyal MJ; Harish BN; Bhat V; Parija SC
Indian J Med Microbiol; 2009; 27(3):260-3. PubMed ID: 19584512
[TBL] [Abstract][Full Text] [Related]
20. Decreased protein C, protein S, and antithrombin levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei.
LaRosa SP; Opal SM; Utterback B; Yan SC; Helterbrand J; Simpson AJ; Chaowagul W; White NJ; Fisher CJ
Int J Infect Dis; 2006 Jan; 10(1):25-31. PubMed ID: 16290015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
